Literature DB >> 22296192

Cathepsin S as a biomarker: where are we now and what are the future challenges?

Johan Arnlöv.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22296192     DOI： 10.2217/bmm.11.102

Source DB:  PubMed          Journal:  Biomark Med        ISSN： 1752-0363            Impact factor:   2.851


× No keyword cloud information.
  9 in total

Review 1.  Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications.

Authors:  Yinan Hua; Sreejayan Nair
Journal:  Biochim Biophys Acta       Date:  2014-05-09

Review 2.  Cysteine protease cathepsins and matrix metalloproteinases in the development of abdominal aortic aneurysms.

Authors:  Yanwen Qin; Xu Cao; Yaoguo Yang; Guo-Ping Shi
Journal:  Future Cardiol       Date:  2013-01

3.  Cathepsin S silencing induces apoptosis of human hepatocellular carcinoma cells.

Authors:  Xuedi Wang; Li Xiong; Guotang Yu; Dongdong Li; Tao Peng; Daqing Luo; Jing Xu
Journal:  Am J Transl Res       Date:  2015-01-19       Impact factor: 4.060

4.  Cysteinyl cathepsins: multifunctional enzymes in cardiovascular disease.

Authors:  Xiang Li; Zexuan Liu; Zeen Cheng; Xianwu Cheng
Journal:  Chonnam Med J       Date:  2012-08-24

5.  Role of Cathepsin S in Periodontal Inflammation and Infection.

Authors:  S Memmert; A Damanaki; A V B Nogueira; S Eick; M Nokhbehsaim; A K Papadopoulou; A Till; B Rath; S Jepsen; W Götz; C Piperi; E K Basdra; J A Cirelli; A Jäger; J Deschner
Journal:  Mediators Inflamm       Date:  2017-12-06       Impact factor: 4.711

6.  Cathepsin S inhibition combines control of systemic and peripheral pathomechanisms of autoimmune tissue injury.

Authors:  Maia Tato; Santhosh V Kumar; Yajuan Liu; Shrikant R Mulay; Solange Moll; Bastian Popper; Jonathan N Eberhard; Dana Thomasova; Arne Christian Rufer; Sabine Gruner; Wolfgang Haap; Guido Hartmann; Hans-Joachim Anders
Journal:  Sci Rep       Date:  2017-06-05       Impact factor: 4.379

7.  Cathepsin S Deficiency Mitigated Chronic Stress-Related Neointimal Hyperplasia in Mice.

Authors:  Hailong Wang; Xiangkun Meng; Limei Piao; Aiko Inoue; Wenhu Xu; Chenglin Yu; Kae Nakamura; Lina Hu; Takeshi Sasaki; Hongxian Wu; Kazumasa Unno; Hiroyuki Umegaki; Toyoaki Murohara; Guo-Ping Shi; Masafumi Kuzuya; Xian Wu Cheng
Journal:  J Am Heart Assoc       Date:  2019-07-12       Impact factor: 5.501

8.  Inhibition of cathepsin S produces neuroprotective effects after traumatic brain injury in mice.

Authors:  Jianguo Xu; Handong Wang; Ke Ding; Xinyu Lu; Tao Li; Jiawei Wang; Chunxi Wang; Jian Wang
Journal:  Mediators Inflamm       Date:  2013-10-24       Impact factor: 4.711

9.  Uncovering the cathepsin system in heart failure patients submitted to Left Ventricular Assist Device (LVAD) implantation.

Authors:  Andrea D'Amico; Rosetta Ragusa; Raffaele Caruso; Tommaso Prescimone; Sandra Nonini; Manuela Cabiati; Silvia Del Ry; Maria Giovanna Trivella; Daniela Giannessi; Chiara Caselli
Journal:  J Transl Med       Date:  2014-12-12       Impact factor: 5.531
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.